C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,004 | 76,124 | 162,745 | 281,146 | 94,912 |
| Marketable Securities | 245,170 | 233,155 | 239,326 | 184,765 | 218,567 |
| Receivables | 1,773 | 5,716 | 4,845 | 6,213 | 3,656 |
| TOTAL | $302,946 | $325,689 | $412,294 | $477,561 | $322,011 |
| Non-Current Assets | |||||
| PPE Net | 3,026 | 3,108 | 3,323 | 3,653 | 4,015 |
| Investments And Advances | 130,478 | 142,200 | 78,191 | 32,770 | 32,495 |
| Other Non-Current Assets | 79,035 | 35,768 | 14,103 | 14,437 | 15,486 |
| TOTAL | $212,539 | $181,076 | $95,617 | $50,860 | $51,996 |
| Total Assets | $515,485 | $506,765 | $507,911 | $528,421 | $374,007 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 750 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,405 | 4,506 | 3,745 | 4,469 | 3,742 |
| Accrued Expenses | 9,840 | 13,606 | 11,471 | 9,871 | 6,260 |
| TOTAL | $46,988 | $51,246 | $48,687 | $44,166 | $37,653 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,194 | 10,768 | 10,588 | 10,409 | 10,231 |
| Deferred Revenues | 31,266 | 31,800 | 32,294 | 28,695 | 26,565 |
| Other Non-Current Liabilities | 74,754 | 30,777 | 10,920 | 11,230 | 11,532 |
| TOTAL | $103,968 | $65,913 | $60,444 | $67,828 | $72,649 |
| Total Liabilities | $150,956 | $117,159 | $109,131 | $111,994 | $110,302 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,797 | 48,739 | 48,626 | 48,454 | 43,195 |
| Common Shares | 5 | 5 | 5 | 5 | 4 |
| Retained earnings | -299,335 | -267,715 | -252,057 | -227,374 | -204,794 |
| Other shareholders' equity | -3,650 | -775 | -155 | -69 | -94 |
| TOTAL | $364,529 | $389,606 | $398,780 | $416,427 | $263,705 |
| Total Liabilities And Equity | $515,485 | $506,765 | $507,911 | $528,421 | $374,007 |